Schoch Steven J 4

What Happened

• Steven J. Schoch, a director of Zura Bio Ltd (ZURA), received a grant/award of a derivative security covering 51,000 shares on June 17, 2026. The reported acquisition price is $0.00 (no cash paid at grant in the filing). This was an award/grant (compensation), not a market purchase or sale.

Key Details

• Transaction date: 2026-06-17. Form 4 filed: 2026-06-22 (filed 5 days after the transaction; Form 4s are typically required within 2 business days).
• Transaction code/type: A = Grant/Award of a derivative security.
• Quantity and price: 51,000 shares; reported price $0.00 (derivative award).
• Shares owned after transaction: Not specified in the provided excerpt—see the full Form 4 for total beneficial ownership.
• Footnote (vesting): The award vests in twelve substantially equal monthly installments over one year beginning June 17, 2026; any remaining unvested portion will vest as of the day before the next annual shareholders’ meeting, subject to continued service.

Context

• This was a compensated equity award (a derivative grant subject to vesting), not an exercise or sale. Such grants are common for directors as service compensation and do not by themselves indicate buying or selling sentiment in the market. Check the full Form 4 for total holdings, exact award type (e.g., options vs. RSUs), and any further terms.